← Browse by Condition
Medical Condition
peripheral arterial disease
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 3, Phase 4
ClinicalMetric tracks all active clinical trials for peripheral arterial disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — peripheral arterial disease Clinical Trials
How many clinical trials are currently recruiting for peripheral arterial disease?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for peripheral arterial disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for peripheral arterial disease?
peripheral arterial disease research spans Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a peripheral arterial disease clinical trial?
Eligibility criteria for peripheral arterial disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT01904851
Recruiting
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Enrollment
14,000 pts
Location
United States
Sponsor
Baylor Research Institute
NCT04027244
Recruiting
Leg Ischaemia Management Collaboration
Enrollment
420 pts
Location
United Kingdom
Sponsor
University of Leicester
NCT03195556
Recruiting
Augmentation of Limb Perfusion With Contrast Ultrasound
Enrollment
30 pts
Location
United States
Sponsor
Oregon Health and Science Univ...
NCT07223593 Phase 3
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Enrollment
1,205 pts
Location
United States, Argen...
Sponsor
Eli Lilly and Company
NCT06952543
Recruiting
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
Enrollment
400 pts
Location
United States
Sponsor
Mayo Clinic
NCT05854641 Phase 4
Recruiting
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease
Enrollment
10 pts
Location
Malaysia
Sponsor
Cell Biopeutics Resources Sdn ...
NCT03663777
Recruiting
Handgrip Training in Patients With Peripheral Artery Disease
Enrollment
30 pts
Location
Brazil
Sponsor
University of Nove de Julho
NCT06573437
Recruiting
Clinical Performance of the VESTO® Vascular Stent for Treatment of Iliac Peripheral Obstructive Arterial Disease
Enrollment
100 pts
Location
Brazil
Sponsor
Braile Biomedica Ind. Com. e R...
NCT05749250
Recruiting
Ultrasound Cavitation Therapy for CLI
Enrollment
30 pts
Location
United States
Sponsor
University of Virginia
NCT06989216
Recruiting
Multi-modal Quantitative Imaging of the Skin
Enrollment
8,000 pts
Location
Sweden
Sponsor
HJN Sverige AB/Neko Health
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology